Accenture Announces Collaboration With Bayer to Streamline Drug Development Processes Through INTIENT Clinical Platform
September 16, 2019
September 16, 2019
NEW YORK, Sept. 16 -- Accenture, a global professional services company, issued the following news release:
Accenture (NYSE: ACN) has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes. The platform, which went live at Bayer earlier this year, brings internal and external clinical data together with Oracle cloud-based technologies into a single data management and warehousing platform, c . . .
Accenture (NYSE: ACN) has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes. The platform, which went live at Bayer earlier this year, brings internal and external clinical data together with Oracle cloud-based technologies into a single data management and warehousing platform, c . . .